Vigilare Wealth Management Clovis Oncology, Inc. Transaction History

Vigilare Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 29, 2021	SELL	$4.81 - $10.34 $154,882 - $332,948	-32,200 Closed	0 $0
Q4 2020 Jan 14, 2021	SELL	$4.13 - $6.41 $15,900 - $24,678	-3,850 Reduced 10.68%	32,200 $155,000
Q3 2020 Oct 15, 2020	BUY	$4.82 - $7.72 $7,471 - $11,966	1,550 Added 4.49%	36,050 $210,000
Q2 2020 Jul 20, 2020	BUY	$5.69 - $9.69 $112,889 - $192,249	19,840 Added 135.33%	34,500 $233,000
Q1 2020 May 04, 2020	BUY	$3.77 - $11.0 $55,268 - $161,260	14,660 New	14,660 $93,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.